{"id":"W4403789396","doi":"10.1016/j.ygyno.2024.10.013","title":"Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha–expressing recurrent ovarian cancer: An integrated safety summary","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"ImmunoGen","keywords":"Medicine; Tolerability; Ovarian cancer; Oncology; Folate receptor; Internal medicine; Gynecology; Cancer; Adverse effect; Cancer cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002341551,0.000394288,0.001377628,0.0003431521,0.0001981508,0.0008915471,0.0003521614,0.0005149895,0.001416048],"category_scores_gemma":[0.001812974,0.0001836147,0.001494787,0.0003782032,0.0002561204,0.0004460855,0.0001475401,0.001042745,0.000376194],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007835089,"about_ca_system_score_gemma":0.000753154,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004932015,"about_ca_topic_score_gemma":0.001147014,"domain_scores_codex":[0.9990983,0.0003740493,0.0001136798,0.00009262574,0.0002436989,0.00007768964],"domain_scores_gemma":[0.9984658,0.0004591141,0.0005947649,0.00009887586,0.0002631219,0.000118364],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1027158,0.00297123,0.05247499,0.003011261,0.005694535,0.0005884553,0.0003686156,0.007289198,0.09166726,0.0005301257,0.004213739,0.7284748],"study_design_scores_gemma":[0.02390985,0.3448259,0.4855359,0.00088195,0.01520536,0.00478037,0.000453924,0.01466107,0.05945813,0.001030373,0.0490261,0.0002310709],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9565769,0.03138828,0.003239934,0.0007676841,0.00008937644,0.0004368075,0.001512149,0.0002087334,0.005780083],"genre_scores_gemma":[0.9901713,0.005111058,0.001129126,0.0005431465,0.0001302203,0.0001320945,0.001352123,0.00003640163,0.001394597],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002341551,"threshold_uncertainty_score":0.01238346,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05559084458819756,"score_gpt":0.4069770437203846,"score_spread":0.351386199132187,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}